Triple-negative tumours account for 15% of all breast-cancer cases but are harder to treat - often with poorer outcomes.
The drug, pembrolizumab, given alongside chemotherapy, can help shrink these cancers and stop them spreading. BBC News
See also:
Tuesday, 8 November 2022
NHS reaches deal for life-saving breast-cancer drug
NHS reaches deal for life-saving breast-cancer drug NHS England has struck a commercial deal to offer a potentially life-saving drug to more patients with a very aggressive type of breast cancer.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment